Skip to main navigation menu Skip to main content Skip to site footer

Special issue on Int Conf Spices

Vol. 11 No. sp3 (2024): International Seminar on Spices KAU - 2024

Phytochemical analysis, therapeutic and molecular docking studies for the compounds of wild type and Senkambu variants of curry leaves targeting HER2 Kinase domain a potential gastric cancer receptor

DOI
https://doi.org/10.14719/pst.4579
Submitted
13 August 2024
Published
25-12-2024 — Updated on 14-02-2025
Versions

Abstract

Gastric cancer is the fifth most notable health concern globally. In recent years, molecular docking, a computational technique, has emerged as tool in drug discovery. The present investigation aimed to identify the major bioactive compounds in the wild-type curry leaves found in the Shevaroy Hills and the local Senkambu variant from Karamadai. Virtual screening of 40 ligands from Curry leaves of wild type and Senkambu type was identified through GC-MS profiling. These compounds were targeted against HER2 Kinase domain which is a potential receptor for Gastric cancer. Information regarding the binding site residues for the receptor was predicted using CASTp server. Molecular docking was performed for HER2 kinase domain with the predicted compounds through GC-MS profiling. The top 3 hits reported with least binding affinity for the target protein were considered for further interaction analysis using Biovia Discovery studio visualizer. Upon analyzing the interacted compounds, the Piperine from Wild type curry leaves was found to have good interaction with HER2 Kinase domain by forming two hydrogen bonds and binding score of -8.3 kcal/mol. The current study might guide the designing of analogues of piperine in the evolution of effective broad spectrum drug development in cancer therapy.

References

  1. Mamun TI, Younus S, Rahman MH. Gastric cancer-epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treatment and Res Commun.2024;24:100845.https://doi.org/10.1016/j.ctarc.2024.100845
  2. Scheck MK, Hofheinz RD, Lorenzen S. HER2-positive gastric cancer and antibody treatment: State of the art and future de-velopments. Cancers. 2024;29(7):1336. https://doi.org/10.3390/cancers16071336
  3. Takiuchi H, Ohtsu A, Fuse N, Goto M, Yoshida M, Dote N, et al. Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. British J Cancer. 2012;106(4):666-72. https://doi.org/10.1038/bjc.2011.590
  4. Ho JW, Leung Y, Chan C. Herbal medicine in the treatment of cancer. Curr Med Chem Anti-Cancer Agents. 2002;2(2):209-14. https://doi.org/10.2174/1568011023354164
  5. Sandhya S, Jegadeeswari V, Shoba N, Jeyakumar P. A prelimi-nary study to check the graft compatibility and success percent-age of curry leaf (Murraya koenigii Spreng.). J Pharmaco and Phytochem. 2020;9(4):3479-83.
  6. Noolu B, Ismail A. Anti-proliferative and proteasome inhibitory activity of Murraya koenigii leaf extract in human cancer cell lines. Discovery Phytomed- J Nat Prod Res and Ethnopharma. 2015;25(1):1-9. https://doi.org/10.15562/phytomedicine.2015.18
  7. Balakrishnan R, Vijayraja D, Jo SH, Ganesan P, Su-Kim I, Choi DK. Medicinal profile, phytochemistry and pharmacological activities of Murraya koenigii and its primary bioactive com-pounds. Antioxidants. 2020;24(2):101. https://doi.org/10.3390%2Fantiox9020101
  8. Raghu BR. Diversity and distribution of curry leaf in India. J Hor-ticultural Sci. 2020;15(1):1-8.
  9. Vali DM, Venkatesan K, Senthil N, Selvi BS, Raveendran M. Com-parative analysis of Curcuma species essential oil through gas chromatography-mass spectrometry. Medicinal Plants-Inter J Phytomed and Related Indust. 2022;14(4):632-36.
  10. Santhanakrishnan VP, Shoba N, Varun E, Mohankumar S, Raveendran M. Aromatic profiling of Murraya koenigii leaves by Thermal Desorption Gas chromatography-Mass Spectroscopy (TD-GC-MS). Heliyon. 2023 Jul 1;9(7):
  11. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient opti-mization and multithreading. J Comput Chem. 2010;31(2):455-61.
  12. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chem-istry friendliness of small molecules. Scientific Reports. 2017;7(1):42717.
  13. Shin SA, Lee HN, Choo GS, Kim SJ, Kim HJ, Park YS, et al. Induc-tion of apoptosis and inhibition of growth in human gastric cancer by piperine. J Korean Society of Food Sci and Nutri. 2016;45(11):1589-94. https://doi.org/10.3746/jkfn.2016.45.11.1589
  14. Zadorozhna M, Tataranni T, Mangieri D. Piperine: role in preven-tion and progression of cancer. Mol Biol Reports. 2019;46(5):5617-29.
  15. Turrini E, Sestili P, Fimognari C. Overview of the anticancer po-tential of the “king of spices” Piper nigrum and its main constit-uent piperine. Toxins. 2020;26:(12):747. https://doi.org/10.1186/s43088-022-00196-1
  16. Xia Y, Khoi PN, Yoon HJ, Lian S, Joo YE, Chay KO, et al. Piperine inibits IL-1?-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells. Molecular and Cel-lular Biochem. 2015;398:147-56.
  17. Chen H, Sheng H, Zhao Y, Zhu G. Piperine inhibits cell prolifera-tion and induces apoptosis of human gastric cancer cells by downregulating phosphatidylinositol 3-kinase (PI3K)/Akt path-way. Med Sci Monitor: Inter Med J Experimental and Clinical Res. 2020;26:e928403-1.
  18. Tripathi AK, Ray AK, Mishra SK. Molecular and pharmacological aspects of piperine as a potential molecule for disease preven-tion and management: evidence from clinical trials. Beni-Suef University J of Basic and Applied Sci. 2022;28(1):16. https://doi.org/10.1186/s43088-022-00196-1
  19. Chen B, Zhao Y, Lin Z, Liang J, Fan J, Huang Y, et al. 2. Apatinib and gamabufotalin co-loaded lipid/prussian blue nanoparticles forsynergistic therapy to gastric cancer with metastasis. J Phar-maceutical Analysis. 2023; https://doi.org/10.1016/j.jpha.2023.11.011
  20. Ramos IN, da Silva MF, Lopes JM, Cruz JN, Alves FS, do Rego JD, et al. Extraction, characterization and evaluation of the cytotox-ic activity of piperine in its isolated form and in combination with chemotherapeutics against gastric cancer. Molecules. 2023;28(14):5587. https://doi.org/10.3390/molecules28145587

Downloads

Download data is not yet available.